Atara Biotherapeutics, Inc. 4 filing

Filed 2026-03-19 · Report date 2026-03-17 · 2026

View Original SEC Filing

Filing metadata

Accession number: 0001193125-26-116060
Form type: 4
CIK: 0001604464
Primary document: https://www.sec.gov/Archives/edgar/data/1604464/000119312526116060/xslF345X06/ownership.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Atara Biotherapeutics, Inc..

Reported financial metrics

Metric	Current	Prior	Change